759825

0

CURIS

img img img img
No Data Available

Curis Lifesciences Ltd Share Price Update

CURIS LIFESCIENCES LTD is trading at ₹125 in today's session, down by ₹-3.19 or -2.48% from its previous close, with an intraday range of ₹125.00 – ₹129.00. Over the past six months, the stock has delivered a return of -9.07%. In the last month, it has returned 14.36%.

Curis Lifesciences Ltd performance

Today’s low Today’s high
₹ 125.00 ₹ 129.00
₹ 125.00
52 week low 52 week high
₹ 83.60 ₹ 147.90
₹ 125.00
Open Price ₹ 129.00
Prev. Close ₹ 128.20
Volume (Shares) 6000.00
Total traded value ₹ 7.50
Upper Circuit ₹ 153.80
Lower Circuit ₹ 102.60
info

Curis Lifesciences Ltd fundamentals


  • Market cap (Cr) 101.10
  • P/E Ratio (TTM) 16.98
  • Beta 0.67
  • Book Value / share 54.11
  • Return on equity 55.32%
  • EPS (TTM) 7.55
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 1.34
info icon alternate text
  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) [-]
info icon alternate text

Curis Lifesciences Ltd Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars SEP 2025 (Values in Cr)
Revenue 8.41
Operating Expense 0.00
Net Profit 1.34
Net Profit Margin (%) 15.93
Earnings Per Share (EPS) 2.26
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 19.50
Operating Expense 15.79
Net Profit 2.87
Net Profit Margin (%) 14.71
Earnings Per Share (EPS) 4.84
EBITDA 4.24
Effective Tax Rate (%) 22.84
Particulars MAR 2025 (Values in Cr)
Revenue 50.26
Operating Expense 41.30
Net Profit 6.21
Net Profit Margin (%) 12.35
Earnings Per Share (EPS) 10.87
EBITDA 10.77
Effective Tax Rate (%) 30.92
Particulars MAR 2024 (Values in Cr)
Revenue 35.56
Operating Expense 28.70
Net Profit 4.87
Net Profit Margin (%) 13.69
Earnings Per Share (EPS) 97.34
EBITDA 8.70
Effective Tax Rate (%) 32.21
Particulars MAR 2023 (Values in Cr)
Revenue 35.50
Operating Expense 34.21
Net Profit 1.12
Net Profit Margin (%) 3.15
Earnings Per Share (EPS) 22.44
EBITDA 3.68
Effective Tax Rate (%) 30.86
Particulars MAR 2022 (Values in Cr)
Revenue 23.74
Operating Expense 22.63
Net Profit 0.78
Net Profit Margin (%) 3.28
Earnings Per Share (EPS) 15.63
EBITDA 3.48
Effective Tax Rate (%) 29.72
Particulars MAR 2025 (Values in Cr)
Book Value / Share 27.34
ROE % 55.32
ROCE % 34.13
Total Debt to Total Equity 1.48
EBITDA Margin 20.46
Particulars MAR 2024 (Values in Cr)
Book Value / Share 117.46
ROE % 152.90
ROCE % 40.46
Total Debt to Total Equity 5.38
EBITDA Margin 24.47
Particulars MAR 2023 (Values in Cr)
Book Value / Share 6.45
ROE % 246.00
ROCE % 16.48
Total Debt to Total Equity 0.00
EBITDA Margin 10.16
Particulars MAR 2022 (Values in Cr)
Book Value / Share -18.07
ROE % 98.00
ROCE % 15.66
Total Debt to Total Equity 0.00
EBITDA Margin 15.16
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.30
Total Assets 42.53
Total Liabilities 42.53
Total Equity 16.22
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 14.35
Return on Capital (%) 19.17
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.41
Total Assets 33.81
Total Liabilities 33.81
Total Equity 5.67
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 15.84
Return on Capital (%) 23.53
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.15
Total Assets 29.66
Total Liabilities 29.66
Total Equity 0.32
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 4.13
Return on Capital (%) 7.42
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 27.39
Total Liabilities 27.39
Total Equity -0.90
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 1.79
Return on Capital (%) 2.94
Particulars MAR 2024 (Values in Cr)
Net Income 7.22
Cash from Operations 1.73
Cash from Investing -0.06
Cash from Financing 0.04
Net change in Cash 0.26
Free Cash Flow 1.81
Particulars MAR 2023 (Values in Cr)
Net Income 1.54
Cash from Operations 3.34
Cash from Investing -0.54
Cash from Financing -2.75
Net change in Cash 0.04
Free Cash Flow 3.96
Particulars MAR 2022 (Values in Cr)
Net Income 1.22
Cash from Operations 4.94
Cash from Investing -0.37
Cash from Financing -4.57
Net change in Cash 0.00
Free Cash Flow 5.34
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.34 14.00 1.67 247.83 23.12 40.44
BLISS GVS PHARMA LTD. 278.20 22.51 2.46 2943.05 117.20 293.15
CIPLA LTD 1431.55 28.35 3.35 115640.69 1165.55 1672.20
FERMENTA BIOTECH LIMITED 295.25 9.82 2.22 868.95 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.34 31.10 4.50 247.83 23.12 40.44
AMRUTANJAN HEALTH CARE LTD. 558.00 25.01 4.35 1613.21 490.00 789.95
ASTRAZENECA PHARMA IND LT 8488.45 102.01 26.55 21221.13 7630.00 10653.05
BLISS GVS PHARMA LTD. 278.20 29.91 2.54 2943.05 117.20 293.15

Curis Lifesciences Ltd shareholding pattern

Holding
24.97%
68.03%
1.18%
5.8%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

Curis Lifesciences Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
125.00 -2.49 redarrow
red-green-graph indicator
6 Bearish
10 Bullish
  • 5 Days 129.80
  • 26 Days 119.20
  • 10 Days 127.40
  • 50 Days 113.90
  • 12 Days 126.30
  • 100 Days 115.30
  • 20 Days 121.80
  • 200 Days 113.50
128.20 PIVOT
First Support 128.20 First Resistance 128.20 Second Support 128.20 Second Resistance 128.20 Third Support 128.20 Third Resistance 128.20
RSI 61.23 ADX 62.65 MACD 7.10 Williams % R -44.96 Commodity Channel Index (CCI) 69.04
Date 2026-05-15 Week 4167.00 Same Day 2000.00 Month 5900.00
1 Year 0.67 3 Year 0.67
Over 1 Month
14.36% down
Over 1 Year
-9.07% down
Over 3 Months
23.26% down
Over 3 Years
0.00% down
Over 6 Months
-4.29% down
Over 5 Years
0.00% down

Curis Lifesciences Ltd Corporate Actions

Top Gainers

Top Losers

Curis Lifesciences Ltd Share Price

Curis Lifesciences Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name and style of 'M/s Loreto Pharmaceutacals', pursuant to a Deed of Partnership dated 2 June, 2010. Thereafter ' M/s Loreto Pharmaceutacals' was converted from Partnership Firm to a Private Limited Company as 'Curis Lifesciences Private Limited' and received a Certificate of Incorporation dated on March 23rd, 2016 issued by Registrar of Companies, Ahmedabad. Subsequently, Company was converted into a Public Limited Company and the name of the Company was changed from 'Curis Lifesciences Private Limited' to 'Curis Lifesciences Limited' vide certified incorporated upon the conversion dated August 9, 2024, issued by the Central Processing Centre, Manesar.

Company's business is related to manufacturing of pharmaceutical products for different markets globally as well as domestic. The business is majorly on product to product basis with different marketers. Company has commenced manufacturing facility in year 2017, hence, it has experience of more than 7 years in the current line of business of the Company. The manufacturing facility of the Company is installed with capacity to manufacture 138 Crore tables / year, 15.75 Crore Capsules / year, 1,080 Kilolitre Oral Liquid/ year, 270 Tons external preparation / year and 45 Tons sterile ophthalmic ointment / year. It deal in Pharmaceutical products like Tablets, Capsules, External Preparations, Oral Liquid, Sterile Ophthalmic Ointments etc.

The Company's past and present clientele includes renowned pharma marketers and manufactures namely Arova Pharma, Express Pharmaceuticals Private Limited, Angle Biogenics Private Limited, Centurion Healthcare Private Limited, Costcon Healthcare LLP, J.B. Chemical & Pharmaceuticals Limited, Venus international, Makers Laboratories Limited and Torikaa Pharmaceuticals Limited etc. pharmaceutical manufacturing facility are situated at Sanand GIDC-II in Ahmedabad district of Gujarat, which offers easy and convenient accessibility.

Company launched the IPO by raising a fresh issue of Rs 27.52 Crore and issued 21,50,000 equity shares of Rs 10 by way of IPO in Nov'25.

Parent organization Indian Private
NSE symbol CURIS
Founded 2016
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Curis Lifesciences Ltd?

Answer Field

Curis Lifesciences Ltd share price is for NSE ₹ 125.00 & for BSE ₹ 0.00 as on May 18 2026 01:51 PM.

What is the Market Cap of Curis Lifesciences Ltd Share?

Answer Field

The market cap of Curis Lifesciences Ltd for NSE ₹ 101.10 & for BSE ₹ 0.00 as on May 18 2026 01:51 PM.

What is the 52 Week High and Low of Curis Lifesciences Ltd?

Answer Field

The 52 Week High and Low of Curis Lifesciences Ltd for NSE is ₹ 147.90 and ₹ 83.60 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Curis Lifesciences Ltd?

Answer Field

The 1 year returns on the stock has been -9.07%.

What is the P/E Ratio of Curis Lifesciences Ltd Share?

Answer Field

As on May 18 2026 01:51 PM the price-to-earnings (PE) ratio for Curis Lifesciences Ltd share is 16.98.

What is the PB ratio of Curis Lifesciences Ltd Share?

Answer Field

As on May 18 2026 01:51 PM, the price-to-book (PB) ratio for Curis Lifesciences Ltd share is 54.11.

How to Buy Curis Lifesciences Ltd Share?

Answer Field

You can trade in Curis Lifesciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Curis Lifesciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Curis Lifesciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Curis Lifesciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|